CCO Oncology Podcast artwork

Strategies for Secondary AML and Emerging Therapies for AML

CCO Oncology Podcast

English - January 10, 2022 18:00 - 15 minutes - 14.3 MB
Courses Education Health & Fitness Medicine essential thrombocythemia myelofibrosis oncology cme skin cancer acute myeloid leukemia kidney cancer melanoma gastrointestinal cancer prostate can Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy
Next Episode: Experts Answer Questions on Current and Emerging Options for Hemophilia A Management

In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:

Liposomal cytarabine plus daunorubicin for secondary AMLAn overview of emerging immune-based strategies for AMLEvidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies

Presenter:

Sarah M. Tinsley, PhD, APRN, AOCN
Nurse Practitioner
Courtesy Assistant Professor
Department of Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida